[go: up one dir, main page]

CA2343123A1 - Active substance concentrate with formoterol, suitable for storage - Google Patents

Active substance concentrate with formoterol, suitable for storage Download PDF

Info

Publication number
CA2343123A1
CA2343123A1 CA002343123A CA2343123A CA2343123A1 CA 2343123 A1 CA2343123 A1 CA 2343123A1 CA 002343123 A CA002343123 A CA 002343123A CA 2343123 A CA2343123 A CA 2343123A CA 2343123 A1 CA2343123 A1 CA 2343123A1
Authority
CA
Canada
Prior art keywords
storage
active substance
formoterol
substance concentrate
concentrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002343123A
Other languages
French (fr)
Other versions
CA2343123C (en
Inventor
Dieter Hochrainer
Bernd Zierenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19847969A external-priority patent/DE19847969A1/en
Application filed by Individual filed Critical Individual
Publication of CA2343123A1 publication Critical patent/CA2343123A1/en
Application granted granted Critical
Publication of CA2343123C publication Critical patent/CA2343123C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to a formoterol active substance concentrate suitable for storage, in the form of a solution or suspension for use in inhalers for inhalation or nasal therapy.
CA002343123A 1998-10-17 1999-10-09 Active substance concentrate with formoterol, suitable for storage Expired - Fee Related CA2343123C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19847969.7 1998-10-17
DE19847969A DE19847969A1 (en) 1998-10-17 1998-10-17 Stable liquid formulation of formoterol in solution or suspension medium, used after dilution for treatment of asthma by inhalation
US11238098P 1998-12-14 1998-12-14
US60/112,380 1998-12-14
PCT/EP1999/007581 WO2000023065A2 (en) 1998-10-17 1999-10-09 Storable active substance concentrate with formoterol

Publications (2)

Publication Number Publication Date
CA2343123A1 true CA2343123A1 (en) 2000-04-27
CA2343123C CA2343123C (en) 2008-03-25

Family

ID=26049594

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002343123A Expired - Fee Related CA2343123C (en) 1998-10-17 1999-10-09 Active substance concentrate with formoterol, suitable for storage

Country Status (26)

Country Link
EP (1) EP1121112B1 (en)
JP (2) JP3636430B2 (en)
KR (1) KR100655100B1 (en)
CN (1) CN1187044C (en)
BG (1) BG65350B1 (en)
BR (1) BR9914507A (en)
CA (1) CA2343123C (en)
CZ (1) CZ20011362A3 (en)
DE (1) DE59901669D1 (en)
DK (1) DK1121112T3 (en)
EA (1) EA003960B1 (en)
EE (1) EE04219B1 (en)
ES (1) ES2178479T3 (en)
HK (1) HK1041448B (en)
HR (1) HRP20010255A2 (en)
HU (1) HUP0103925A3 (en)
ID (1) ID29605A (en)
IL (2) IL142494A0 (en)
NO (1) NO20011663L (en)
NZ (1) NZ511225A (en)
PL (1) PL348434A1 (en)
PT (1) PT1121112E (en)
SI (1) SI1121112T1 (en)
SK (1) SK285382B6 (en)
TR (1) TR200101096T2 (en)
WO (1) WO2000023065A2 (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007059620A1 (en) * 2005-11-23 2007-05-31 Feanny Stephen J Method for administering formoterol using a nebulizer
US9545487B2 (en) 2012-04-13 2017-01-17 Boehringer Ingelheim International Gmbh Dispenser with encoding means
US9682202B2 (en) 2009-05-18 2017-06-20 Boehringer Ingelheim International Gmbh Adapter, inhalation device, and atomizer
US9724482B2 (en) 2009-11-25 2017-08-08 Boehringer Ingelheim International Gmbh Nebulizer
US9744313B2 (en) 2013-08-09 2017-08-29 Boehringer Ingelheim International Gmbh Nebulizer
US9757750B2 (en) 2011-04-01 2017-09-12 Boehringer Ingelheim International Gmbh Medicinal device with container
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
US10004857B2 (en) 2013-08-09 2018-06-26 Boehringer Ingelheim International Gmbh Nebulizer
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
US10099022B2 (en) 2014-05-07 2018-10-16 Boehringer Ingelheim International Gmbh Nebulizer
US10124129B2 (en) 2008-01-02 2018-11-13 Boehringer Ingelheim International Gmbh Dispensing device, storage device and method for dispensing a formulation
US10124125B2 (en) 2009-11-25 2018-11-13 Boehringer Ingelheim International Gmbh Nebulizer
US10195374B2 (en) 2014-05-07 2019-02-05 Boehringer Ingelheim International Gmbh Container, nebulizer and use
US10722666B2 (en) 2014-05-07 2020-07-28 Boehringer Ingelheim International Gmbh Nebulizer with axially movable and lockable container and indicator

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ2947A1 (en) 1998-11-25 2004-03-15 Chiesi Farma Spa Pressure metered dose inhaler.
IT1313553B1 (en) 1999-07-23 2002-09-09 Chiesi Farma Spa OPTIMIZED FORMULATIONS CONSTITUTED BY SOLUTIONS OF STEROIDS GIVEN BY INHALATION.
IT1317846B1 (en) 2000-02-22 2003-07-15 Chiesi Farma Spa FORMULATIONS CONTAINING AN ANTICOLINERGIC DRUG FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE BRONCOPNEUMOPATHY.
UA73986C2 (en) * 2000-05-22 2005-10-17 К'Єзі Фармачеутічі С.П.А. Aerosol solution composition containing beta-2 adrenergic agonist of prolonged action, dosing pressurized inhaler and method for its filling
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) * 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
ITRM20040268A1 (en) * 2004-05-31 2004-08-31 Italchimici S P A PHARMACEUTICAL FORMULATION OF A STABLE FORMOTEROL SOLUTION BY INHALATION AND ON ITS PREPARATION.
ITRM20050022A1 (en) 2005-01-19 2006-07-20 Italchimici S P A PHARMACEUTICAL FORMULATION OF A STABLE SOLUTION OF PROPYLENE GLYCOL CONTAINING FORMOTEROL BY INHALATION AND ITS PREPARATION PROCEDURE.
DE102006023756A1 (en) * 2006-05-20 2007-11-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ethanol-containing aerosol formulation for inhalation
WO2007140285A2 (en) * 2006-05-26 2007-12-06 Dey, L.P. Nebulizable compositions of quaternary ammonium muscarinic receptor antagonists
CN107362140A (en) * 2016-05-11 2017-11-21 广东东阳光药业有限公司 Sprays and Spray Components
WO2020019952A1 (en) * 2018-07-26 2020-01-30 四川海思科制药有限公司 Aerosol pharmaceutical composition containing glycopyrrolate salt and indacaterol salt, preparation method therefor, and uses thereof
CN110755414A (en) * 2019-11-12 2020-02-07 南京华盖制药有限公司 Arformoterol tartrate aerosol and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE150296T1 (en) * 1991-12-18 1997-04-15 Minnesota Mining & Mfg AEROSOL COMPOSITIONS FOR MEDICINAL SUSPENSIONS
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
GB9616237D0 (en) * 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007059620A1 (en) * 2005-11-23 2007-05-31 Feanny Stephen J Method for administering formoterol using a nebulizer
US10124129B2 (en) 2008-01-02 2018-11-13 Boehringer Ingelheim International Gmbh Dispensing device, storage device and method for dispensing a formulation
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
US9682202B2 (en) 2009-05-18 2017-06-20 Boehringer Ingelheim International Gmbh Adapter, inhalation device, and atomizer
US10124125B2 (en) 2009-11-25 2018-11-13 Boehringer Ingelheim International Gmbh Nebulizer
US9724482B2 (en) 2009-11-25 2017-08-08 Boehringer Ingelheim International Gmbh Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
US9757750B2 (en) 2011-04-01 2017-09-12 Boehringer Ingelheim International Gmbh Medicinal device with container
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
US9545487B2 (en) 2012-04-13 2017-01-17 Boehringer Ingelheim International Gmbh Dispenser with encoding means
US10220163B2 (en) 2012-04-13 2019-03-05 Boehringer Ingelheim International Gmbh Nebuliser with coding means
US10004857B2 (en) 2013-08-09 2018-06-26 Boehringer Ingelheim International Gmbh Nebulizer
US9744313B2 (en) 2013-08-09 2017-08-29 Boehringer Ingelheim International Gmbh Nebulizer
US10894134B2 (en) 2013-08-09 2021-01-19 Boehringer Ingelheim International Gmbh Nebulizer
US11642476B2 (en) 2013-08-09 2023-05-09 Boehringer Ingelheim International Gmbh Nebulizer
US10716905B2 (en) 2014-02-23 2020-07-21 Boehringer Lngelheim International Gmbh Container, nebulizer and use
US10099022B2 (en) 2014-05-07 2018-10-16 Boehringer Ingelheim International Gmbh Nebulizer
US10195374B2 (en) 2014-05-07 2019-02-05 Boehringer Ingelheim International Gmbh Container, nebulizer and use
US10722666B2 (en) 2014-05-07 2020-07-28 Boehringer Ingelheim International Gmbh Nebulizer with axially movable and lockable container and indicator

Also Published As

Publication number Publication date
CN1333682A (en) 2002-01-30
BR9914507A (en) 2001-06-26
JP2002527473A (en) 2002-08-27
ID29605A (en) 2001-09-06
TR200101096T2 (en) 2001-12-21
BG65350B1 (en) 2008-03-31
PT1121112E (en) 2002-11-29
SK4942001A3 (en) 2001-09-11
HUP0103925A3 (en) 2003-05-28
WO2000023065A8 (en) 2001-02-22
WO2000023065A3 (en) 2000-08-03
JP3636430B2 (en) 2005-04-06
WO2000023065A2 (en) 2000-04-27
SI1121112T1 (en) 2002-10-31
HUP0103925A2 (en) 2002-05-29
CA2343123C (en) 2008-03-25
DK1121112T3 (en) 2002-09-16
PL348434A1 (en) 2002-05-20
NZ511225A (en) 2003-08-29
SK285382B6 (en) 2006-12-07
CN1187044C (en) 2005-02-02
EE04219B1 (en) 2004-02-16
IL142494A0 (en) 2002-03-10
DE59901669D1 (en) 2002-07-11
JP2005047933A (en) 2005-02-24
CZ20011362A3 (en) 2001-09-12
NO20011663D0 (en) 2001-04-03
KR20010075637A (en) 2001-08-09
IL142494A (en) 2006-04-10
KR100655100B1 (en) 2006-12-08
NO20011663L (en) 2001-04-03
EE200100224A (en) 2002-06-17
EA200100439A1 (en) 2001-10-22
BG105391A (en) 2001-11-30
ES2178479T3 (en) 2002-12-16
HK1041448A1 (en) 2002-07-12
HK1041448B (en) 2005-05-13
EP1121112A2 (en) 2001-08-08
EP1121112B1 (en) 2002-06-05
EA003960B1 (en) 2003-10-30
HRP20010255A2 (en) 2002-04-30

Similar Documents

Publication Publication Date Title
CA2343123A1 (en) Active substance concentrate with formoterol, suitable for storage
MY124329A (en) Active substance concentrate with formoterol, suitable for storage.
US5518998C1 (en) Therapeutic preparation for inhalation
CA2257329A1 (en) Nebulized budesonide for the treatment of respiratory diseases
CA2123909A1 (en) New combination of formoterol and budesonide
MX9800864A (en) Ipratropium bromide enantiomer with a prolonged duration of action.
SI1007017T2 (en) Budesonide/formoterol formulation for inhalation having a poured bulk density of 0.30 to 0.36 g/ml, a process for preparing the formulation and the use thereof
CA2369722A1 (en) Powder inhaler for combined medicament
CA2386690A1 (en) Pharmaceutical tramadol salts
MY129512A (en) Novel medicament compositions, based on tiotropium bromide and salmeterol
NZ506289A (en) Aerosolized active agent delivery to the lungs at a flow rate of less than 17 liters per minute
BR0009480A (en) Polyurethane solutions with alkoxysilane structure units
CA2024916A1 (en) Respiratory disorder medicaments comprising salmeterol and fluticasone propionate
BR9505771A (en) Children's spacer basically intended to be used in conjunction with a metered dose inhaler
CA2021534A1 (en) Antiallergic spray preparations
DE69821119D1 (en) INNOVATIVE FORMULATION FOR INHALATION WITH A BULK DENSITY BETWEEN 0.28 AND 0.38 G / ML, WITH FORMOTEROL
AU6095099A (en) Nasal respirator for treating respiratory disorders, in particular sleep apnea
MX9805141A (en) USE OF INHIBITORS OF THE CELLULAR Na+/H+ EXCHANGER (NHE) FOR THE PREPARATION OF A DRUG FOR RESPIRATORY STIMULATION.
AU3598299A (en) Improved compositions for inhalation
CA2354576A1 (en) Pharmaceutical preparation for inhalation of an opioid
AU1665992A (en) Novel taurine-based pharmaceutical composition for administration by inhalation
WO1999049892A3 (en) Use of active p40 conjugates for nasal delivery
EP0919229A3 (en) Anti-reactive anti-asthmatic activity of non-steroidal anti-inflammatory drugs by inhalation
ECSP993179A (en) ACTIVE SUBSTANCE CONCENTRATE WITH FORMOTEROL, SUITABLE FOR STORAGE
Aksenova Ultrasonic inhalation of antibacterial drugs combined treatment of children and adolescents with respiratory tuberculosis.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed